IRADIMED CORPORATION Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent
IRADIMED CORPORATION (IRMD) reported Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent of 7.20% for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-06.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities · last filed 2020-03-06
- IRADIMED CORPORATION effective income tax rate reconciliation, deduction, qualified production activity, percent for the quarter ending 2017-03-31 was 15.20%, a 462.96% increase year-over-year.
- IRADIMED CORPORATION effective income tax rate reconciliation, deduction, qualified production activity, percent for the quarter ending 2016-03-31 was 2.70%.
- IRADIMED CORPORATION effective income tax rate reconciliation, deduction, qualified production activity, percent for the quarter ending 2015-03-31 was -2.70%.
- IRADIMED CORPORATION effective income tax rate reconciliation, deduction, qualified production activity, percent for fiscal 2017 was 7.20%, a 148.28% increase from fiscal 2016.
- IRADIMED CORPORATION effective income tax rate reconciliation, deduction, qualified production activity, percent for fiscal 2016 was 2.90%, a 61.11% increase from fiscal 2015.
- IRADIMED CORPORATION effective income tax rate reconciliation, deduction, qualified production activity, percent for fiscal 2015 was 1.80%, a 14.29% decline from fiscal 2014.
- IRADIMED CORPORATION effective income tax rate reconciliation, deduction, qualified production activity, percent for fiscal 2014 was 2.10%.
| Period end | Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent 3 month | Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent 3 month as first filed | Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent 12 month | Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent 12 month as first filed |
|---|---|---|---|---|
| 2017-12-31 | 7.20% 10-K · filed 2020-03-06 | |||
| 2017-03-31 | 15.20% 10-Q · filed 2017-05-05 | |||
| 2016-12-31 | 2.90% 10-K · filed 2019-03-07 | |||
| 2016-03-31 | 2.70% 10-Q · filed 2017-05-05 | -2.70% 10-Q · filed 2016-05-06 | ||
| 2015-12-31 | 1.80% 10-K · filed 2018-03-08 | -1.80% 10-K · filed 2016-03-10 | ||
| 2015-03-31 | -2.70% 10-Q · filed 2016-05-06 | |||
| 2014-12-31 | 2.10% 10-K · filed 2017-03-10 | -2.10% 10-K · filed 2015-03-23 | ||
| 2013-12-31 | -3.70% 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |